Literature DB >> 20862825

Community-associated methicillin-resistant Staphylococcus aureus infections in Israel.

Alon Nevet1, Shai Ashkenazi, Zmira Samra, Gilat Livni.   

Abstract

BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus infections are increasingly being documented worldwide. In Israel, however, CA-MRSA infections have not yet been reported, so awareness among physicians may be low.
OBJECTIVE: To alert physicians to the possibility of CA-MRSA infection, which necessitates a distinct therapeutic approach.
METHODS: We present three children with soft tissue infections caused by CA-MRSA who were treated in our medical center from January to March 2009.
RESULTS: In all three cases CA-MRSA was identified as the causative pathogen after surgical or spontaneous drainage. On susceptibility testing, the organisms were resistant to beta-lactam antibiotics but susceptible to clindamycin, rifampicin and trimethoprim-sulfamethoxazole.
CONCLUSIONS: Physicians should maintain an index of suspicion for CA-MRSA infections. The antibiotic-resistance profile of S. aureus should be watched carefully, and in particular, cultures should be obtained whenever soft tissue infections fail to respond to conventional treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862825

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  1 in total

1.  Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel.

Authors:  E Berla-Kerzhner; A Biber; M Parizade; D Taran; G Rahav; G Regev-Yochay; D Glikman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.